GNE-7915
Selleck Chemicals
SKU:S7528-10MG
Couldn't load pickup availability

GNE-7915 is an inhibitor of LRRK2 used in studies of Autophagy. It is especially relevant when investigators need a named chemical input and interpretable readouts connected to autophagic flux, lysosomal turnover, and stress adaptation in autophagy, cancer, and cell signaling models.
By inhibiting LRRK2, GNE-7915 can be used to examine autophagic flux, lysosomal turnover, and stress adaptation. The kinase annotation adds relevance to biochemical kinase assays, phospho-signaling studies, and selectivity profiling, together with downstream-response mapping in the same experimental setting. In autophagy, cancer, and cell signaling models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.
Research Applications
- Target-focused assays involving LRRK2
- Pathway perturbation studies connected to Autophagy
- Concentration-response inhibition and target-dependence studies
- Biochemical kinase assays, phospho-signaling studies, and selectivity profiling
Overall, GNE-7915 is appropriate when a defined chemical perturbant is needed to connect LRRK2 with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in autophagy, cancer, and cell signaling models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.
- Targets:
- LRRK2
- Target Class:
- Kinase
- Pathways:
- Autophagy
- Research Area:
- Autophagy • Cancer • Cell Signaling • Neuroscience
- CAS No.:
- 1351761-44-8
- Molecular Weight:
- 443.40
- Formula:
- C₁₉H₂₁F₄N₅O₃
- SMILES:
- CCNC1=NC(=NC=C1C(F)(F)F)NC2=C(C=C(C(=C2)F)C(=O)N3CCOCC3)OC
- Storage Temperature:
- -20°C
For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.
The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.